Based on this evidence and our preliminary observations, the PSA immunoreactivity may be an indicator of functional steroid hormone receptors and endogenous hormone balance between estrogen, androgen, and progestin in breast cancer cells. This evidence concerns the gene KLK3 and breast carcinoma.